The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
The substitution of leucine for valine at amino acid position 34 of the factor XIII gene is commonly referred to as FXIII Val34Leu polymorphism. The homozygous leucine/leucine genotype has been reported to confer protection against venous thromboembolism, but previous studies have not evaluated a population limited to those with idiopathic venous thromboembolism. The primary objective of the study was to determine whether the FXIII Val34Leu polymorphism is independently associated with the occurrence of idiopathic venous thromboembolism. We prospectively enrolled consecutive patients with at least one objectively confirmed idiopathic venous thromboembolism. Friends of cases were recruited as controls and matched to cases by sex, ethnicity, and age. All participants were tested for the FXIII Val34Leu polymorphism in addition to several well-known thrombophilias. Data from 309 cases and 306 controls were analyzed. The FXIII leucine/leucine genotype was present in 4.9% of cases and 6.5% of controls. An adjusted odds ratio of 0.59 (95% confidence interval, 0.25-1.38) was found for the recessive model and 0.69 (95% confidence interval, 0.46-1.02) for the dominant model. Our results do not support an independent association of the FXIII Val34Leu polymorphism with idiopathic venous thromboembolism in our Caucasian Canadian study population.
Wells
Philip S
PS
Department of Medicine, University of Ottawa and the Ottawa Health Research Institute, Ottawa, Ontario, Canada. pwells@ohri.ca
Anderson
Josdalyne L
JL
Rodger
Marc A
MA
Carson
Nancy
N
Grimwood
Rebecca L
RL
Doucette
Steve P
SP
D019943:Amino Acid Substitution / Q000235:genetics; D016022:Case-Control Studies; D005176:Factor XIII / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007930:Leucine / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D018570:Risk Assessment; D013923:Thromboembolism / Q000235:genetics*; D014633:Valine / Q000235:genetics*; D020246:Venous Thrombosis / Q000235:genetics*; D044465:White People / Q000235:genetics
D005176:Factor XIII; D007930:Leucine; D014633:Valine